Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MHRA Proposes Modest Hike in Device User Fees - Medical Product Outsourcing

MHRA Proposes Modest Hike in Device User Fees

New fee takes effect April 1

Devicemakers would pay slightly more to process applications in the UK for clinical trials next year under a proposed fee schedule released by the Medicines and Healthcare products Regulatory Agency (MHRA).

Beginning April 1, 2009, first-time fees for clinical trials of Class I, IIa or IIb devices — other than implantable or long-term invasive devices — would increase from about $4,755 to $4,786. Fees for renotification in the case of an objection or denial would rise to $3,362 from the current $3,230.

SOURCE: FDA NEWS

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters